ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 406 filers reported holding ENCOMPASS HEALTH CORP in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $98,174 | -6.9% | 1,815 | +3.0% | 0.00% | 0.0% |
| Q4 2022 | $105,399 | -23.1% | 1,762 | +0.8% | 0.00% | -25.0% |
| Q2 2021 | $137,000 | 0.0% | 1,748 | +5.8% | 0.00% | -20.0% |
| Q4 2020 | $137,000 | +17.1% | 1,652 | -7.9% | 0.01% | -16.7% |
| Q3 2020 | $117,000 | +9.3% | 1,794 | +7.7% | 0.01% | -14.3% |
| Q1 2020 | $107,000 | -7.0% | 1,665 | 0.0% | 0.01% | +16.7% |
| Q4 2019 | $115,000 | +0.9% | 1,665 | -7.2% | 0.01% | -14.3% |
| Q3 2019 | $114,000 | 0.0% | 1,795 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $114,000 | +26.7% | 1,795 | +16.9% | 0.01% | +16.7% |
| Q1 2019 | $90,000 | -54.8% | 1,535 | -52.4% | 0.01% | -64.7% |
| Q4 2018 | $199,000 | +47.4% | 3,226 | +85.9% | 0.02% | +70.0% |
| Q3 2018 | $135,000 | +3.1% | 1,735 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $131,000 | +32.3% | 1,735 | +0.6% | 0.01% | +25.0% |
| Q1 2018 | $99,000 | +16.5% | 1,725 | 0.0% | 0.01% | +14.3% |
| Q4 2017 | $85,000 | – | 1,725 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
| JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
| Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
| Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
| REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
| AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
| RK Capital | 179,800 | $13,492,000 | 2.55% |
| Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
| BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
| Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |